A study to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of AZD6234 after repeat dose administration in participants who are overweight or obese

Trial Identifier:	D8750C00002
Sponsor:	AstraZeneca
Collaborator:	Parexel
Start Date:	November 2023
Primary Completion Date:	February 2026
Study Completion Date:	February 2026

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
JP	Osaka-shi, JP, 532-0003
US, CA	Glendale, CA, US, 91206
US, MD	Brooklyn, MD, US, 21225

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.